SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,580.54 -1,247.71
( -1.67%)

Global Indices

Nasdaq

51,527.73 -356.96
(-0.69%)

Dow Jones

7,726.85 -58.79
(-0.76%)

Hang Seng

65,657.92 638.97
(0.98%)

Nikkei 225

10,716.75 8.42
(0.08%)

Forex

USD-INR

95.65 -0.17
(-0.17%)

EUR-INR

109.56 -0.37
(-0.34%)

GBP-INR

127.74 -0.44
(-0.34%)

JPY-INR

0.61 0.00
(-0.29%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Alkem Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

539523

INE540L01014

1170.8077615

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ALKEM

28.88

64734.28

EPS(TTM)

Face Value()

Div & Yield %

187.45

0.98

Back

quintegra solutions ltd

Ultracab (India) standalone net profit declines 37.06% in the June 2026 quarter

Aug 13,2026

Net profit of Ultracab (India) declined 37.06% to Rs 1.07 crore in the quarter ended June 2026 as against Rs 1.70 crore during the previous quarter ended June 2025. Sales rose 31.98% to Rs 79.36 crore in the quarter ended June 2026 as against Rs 60.13 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	79.36	60.13	32
OPM %	3.62	6.00	-
PBDT	1.82	2.72	-33
PBT	1.42	2.35	-40
NP	1.07	1.70	-37

73,580.54 -1,247.71 ( -1.67%)

51,527.73 -356.96 (-0.69%)

7,726.85 -58.79 (-0.76%)

65,657.92 638.97 (0.98%)

10,716.75 8.42 (0.08%)

95.65 -0.17 (-0.17%)

109.56 -0.37 (-0.34%)

127.74 -0.44 (-0.34%)

0.61 0.00 (-0.29%)